Mark Bower Selected Research

Castleman Disease (Castleman's Disease)

1/2021	Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease.
1/2017	Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.
1/2014	The use of monoclonal antibodies to treat Castleman's disease.
7/2011	Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease.
2/2010	Follicular dendritic cells in multicentric Castleman disease present human herpes virus type 8 (HHV8)-latent nuclear antigen 1 (LANA1) in a proportion of cases and is associated with an enhanced T-cell response.
5/2009	Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease.
12/2007	Brief communication: rituximab in HIV-associated multicentric Castleman disease.
12/2007	Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease.
9/2004	Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels.
1/2004	Fifty years of multicentric Castleman's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Bower Research Topics

Disease

49	Neoplasms (Cancer) 01/2022 - 01/2003
28	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2021 - 11/2002
28	Acquired Immunodeficiency Syndrome (AIDS) 02/2020 - 07/2003
16	Infections 01/2022 - 02/2003
14	Lymphoma (Lymphomas) 01/2017 - 03/2002
12	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2012 - 09/2003
10	COVID-19 11/2022 - 07/2020
10	Castleman Disease (Castleman's Disease) 01/2021 - 01/2004
10	HIV Infections (HIV Infection) 01/2017 - 02/2003
9	Opportunistic Infections (Opportunistic Infection) 01/2016 - 03/2002
8	Hodgkin Disease (Hodgkin's Disease) 03/2018 - 09/2007
6	Lung Neoplasms (Lung Cancer) 02/2020 - 02/2003
4	Burkitt Lymphoma (Burkitt's Lymphoma) 05/2015 - 04/2003
3	Fever (Fevers) 11/2021 - 09/2005
3	Melanoma (Melanoma, Malignant) 02/2020 - 03/2018
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2010 - 09/2002
3	Carcinogenesis 01/2010 - 02/2003
3	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 03/2004 - 03/2002
2	Fibrosis (Cirrhosis) 11/2021 - 03/2008
2	Liver Neoplasms (Liver Cancer) 01/2019 - 01/2017
2	Hepatitis 01/2019 - 03/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 01/2014
2	Epilepsy (Aura) 08/2014 - 09/2010
2	Hepatitis B 09/2007 - 03/2004
2	Anus Neoplasms (Anal Cancer) 02/2006 - 12/2004
2	Neutropenia 09/2005 - 11/2004
1	Thrombocytopenia (Thrombopenia) 11/2021
1	Primary Effusion Lymphoma 11/2021
1	Ascites 11/2021
1	POEMS Syndrome (Syndrome, POEMS) 11/2021
1	Death (Near-Death Experience) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019
1	Dysbiosis 12/2019
1	HIV Seropositivity 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Papillomavirus Infections 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 11/2021 - 02/2003
7	Rituximab (Mabthera)FDA Link 01/2017 - 12/2007
6	Monoclonal AntibodiesIBA 01/2014 - 09/2004
5	Immune Checkpoint InhibitorsIBA 02/2020 - 01/2019
5	RNA (Ribonucleic Acid)IBA 01/2017 - 03/2002
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 07/2003
5	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2015 - 11/2004
4	DNA (Deoxyribonucleic Acid)IBA 03/2018 - 05/2003
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 09/2004
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 11/2019
3	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2015 - 03/2006
3	Bleomycin (Blenoxane)FDA LinkGeneric 02/2015 - 04/2012
3	Dacarbazine (DIC)FDA LinkGeneric 02/2015 - 04/2012
3	Vinblastine (Vinblastine Sulfate)FDA Link 02/2015 - 04/2012
3	Reverse Transcriptase InhibitorsIBA 12/2004 - 07/2003
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2019
2	B7-H1 AntigenIBA 03/2018 - 01/2017
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2016 - 01/2014
2	Etoposide (VP 16)FDA LinkGeneric 05/2015 - 11/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015 - 11/2004
2	N-acetoacetyl-N-deacetylcolchicineIBA 10/2013 - 02/2009
2	AntigensIBA 07/2011 - 04/2004
2	Imiquimod (Aldara)FDA LinkGeneric 12/2010 - 09/2010
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 09/2010 - 02/2010
2	Pharmaceutical PreparationsIBA 01/2009 - 09/2007
2	AnthracyclinesIBA 11/2004 - 11/2002
2	NucleosidesIBA 02/2004 - 07/2003
1	COVID-19 VaccinesIBA 01/2022
1	Reticulin (Reticular Fiber)IBA 11/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Viral ProteinsIBA 01/2019
1	Fetal Proteins (Fetoprotein)IBA 01/2019
1	CTLA-4 AntigenIBA 01/2019
1	Anti-HIV Agents (AIDS Drugs)IBA 01/2019
1	Cytidine Triphosphate (CTP)IBA 01/2019
1	LigandsIBA 03/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 03/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Nelfinavir (Viracept)FDA Link 01/2016

Therapy/Procedure

48	Therapeutics 11/2022 - 09/2002
48	Highly Active Antiretroviral Therapy (HAART) 01/2017 - 03/2002
26	Drug Therapy (Chemotherapy) 11/2022 - 03/2002
4	Art Therapy 06/2013 - 09/2007
3	Immunotherapy 11/2019 - 04/2004
2	Stem Cell Transplantation 10/2009 - 02/2008
2	Combination Drug Therapy (Combination Chemotherapy) 03/2004 - 03/2002
2	Chemoprevention 02/2004 - 04/2003
1	Continuity of Patient Care 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Palliative Care (Palliative Therapy) 01/2021
1	Terminal Care (Care, Terminal) 01/2021